Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy

NCT02514278 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT02514278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02514278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy
Lead sponsor
University Hospital, Bordeaux
Phase
Phase 3
Overall status
Completed
Start date
January 28, 2016
Completion date
June 30, 2024
Enrollment
218 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer